𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Radioimmunotherapy of carcinoma of colon with [131I]- labeled recombinant chimeric monoclonal antibodies to carcinoembryonic antigen

✍ Scribed by Qiu-jun LU; Guang-xing BIAN; Yuan-yuan CHEN; Min ZHANG; Shao-ming GUO; Li-qing WEN

Book ID
111354909
Publisher
Nature Publishing Group
Year
2005
Tongue
Chinese
Weight
213 KB
Volume
26
Category
Article
ISSN
1671-4083

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Factors influencing hematologic toxicity
Factors influencing hematologic toxicity of radioimmunotherapy with 131I-labeled anti-carcinoembryonic antigen antibodies
✍ Malik E. Juweid; Cun-Hui Zhang; Rosalyn D. Blumenthal; Robert M. Sharkey; Robert πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 117 KB

## METHODS. Ninety-nine patients who received 131 I-labeled anti-CEA MoAb for the Garden State Cancer Center, Center for Molecutreatment of CEA-producing cancers were assessed for platelet and white blood lar Medicine and Immunology, Belleville, New cell toxicity based on the common Radiation Ther

Radioimmunotherapy of experimental pancr
Radioimmunotherapy of experimental pancreatic cancer with 131I-labeled monoclonal antibody PAM4
✍ David V. Gold; Thomas Cardillo; Yehuda Vardi; Rosalynn Blumenthal πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 184 KB

We examined the therapeutic efficacy of 131 I-labeled murine monoclonal antibody (MAb) PAM4 against human pancreatic cancers carried as xenografts in athymic nude mice. Animals bearing the CaPan1 tumor (0.2 cm 3 ) were either untreated or were given, 131 I-labeled nonspecific Ag8 antibody. By week 7